Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
WYKAZAKRONIMÓWWAŻNYCHBADAŃ
TERAPEUTYCZNYCHDOTYCZĄCYCHCUKRZYCY
4S
ABCD
ALLHAT
–
ScandinavianSimvastatinSurvivalStudy
–
AppropriateBloodPressureControlinDiabetes[Trial]
–
AntihipertensiveandLipid–LoweringTreatmenttoPreventHeart
AttackTrial
ASPEN
–
AtorvastatinStudyforPreventionofCoronaryHeartDiseaseEndpoints
inNon-Insulin-DependentDiabetesMellitus
AUSDIAB
–
AustralianDiabetes,ObesityandLifestyleStudy
CARDS
–
CollaborativeAtorvastatinDiabetesStudy
CARE
–
CholesterolandRecurrentEvents[Study]
DAIS
–
DiabetesAtherosclerosisInterventionStudy
DAWN
–
Diabetes,Attitudes,WishesandNeeds[Study]
DCCT
–
DiabetesControlandComplicationsTrial
DIGAMI
–
DiabetesandInsulin–GlucoseInfusioninAcuteMyocardialInfarction
[Study]
DPP
–
DiabetesPreventionProgram[Trial]
FIELD
–
FenofibrateInterventionandEventLoweringinDiabetes[Study]
HERS
–
HeartandEstrogen/ProgestinReplacementStudy
HHS
–
HelsinkiHeartStudy
HIT
–
HDLInterventionTrial
HOPE
–
HeartOutcomesPreventionEvaluation[Study]
HOT
–
HypertensionOptimisationTrial
HPS
–
HeartProtectionStudy
IDNT
–
InternationalDiabeticNephropathyTrial
LIFE
–
LosartanInterventionForEndpointReductioninHypertension[Study]
LIPID
–
Long-termInterventionwithPravastatininIschaemicDisease[Study]
MRFIT
–
MultipleRiskFactorInterventionTrial
NCEP
–
NationalCholesterolEducationProgram
NZGG
–
NewZealandGuidelinesGroup
SHEP
–
SystolicHypertensionintheElderlyProgram
SIGN
–
ScottishIntercollegiateGuidelinesNetwork
SystEur
–
SystolicHypertensioninEurope[Trial]
UKPDS
–
UnitedKingdomProspectiveDiabetesStudy
WHI
–
Women’sHealthInitiative[Study]
WOSCOPS–
WestofScotlandCoronaryPreventionStudy
